Decoy Therapeutics Inc. Common Stock (DCOY)

• Market cap: $4.81M
• 1 day: 6.47%
• 5 days: 47.84%
• 1 month: -1.32%
• 3 months: -81.2%
• 6 months: -92.77%
• Year to date: 25.74%
• 1 year: -96.52%
• 5 years: -99.98%
• 10 years: -100%
• Sector: Healthcare
• Industry: Biotechnology

About: Decoy Therapeutics Inc is a preclinical-stage biotechnology company developing peptide conjugate drug candidates using machine learning, artificial intelligence tools, and high-throughput synthesis techniques. The company's initial pipeline is focused on respiratory viruses and GI cancers.

Employees: 2